News Releases
Latest Headlines
-
McCaskill: How Insys pushed opioid sales
A new report released by Sen. Claire McCaskill reveals how Insys, a pharmaceutical company, aggressively pushed its fentanyl product, Subsys, to increase the number and strength of prescriptions written for it.
-
Inside the drug company accused of putting profit over patients
An NBC News investigation reveals the disturbing tactics the company used to promote a powerful opioid drug. Sen. Claire McCaskill uncovered documents promising big bonuses to its sales team and paying doctors for speeches.
-
Overland Park doctor was a model for opioid firm under indictment, Senate report says
Internal emails from an opioid manufacturer under federal indictment for an alleged kickback scheme show that company executives held Overland Park doctor Steven Simon as one of their models for their sales force.
The emails are included in a report released Tuesday by U.S. Senate committee staffers and provide new details about Simon’s relationship with Insys Therapeutics. The Arizona company’s former leaders face charges they used a physician speaker program to pay doctors for prescribing their fentanyl product Subsys, a highly concentrated opioid sprayed under the tongue.
Photo Gallery
